{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260329952162/en/Positive-Data-from-Phase-2-CADENCE-Trial-Provides-Definitive-Proof-of-Concept-for-WINREVAIR%E2%84%A2-sotatercept-csrk-in-Adults-With-the-Syndrome-of-Combined-Post--and-Precapillary-Pulmonary-Hypertension-and-Heart-Failure-With-Preserved-Ejection-Fraction", "message": "News view counter 632127 successfully enlarged"}